Improving RCC Patient Outcomes

Funding Agency:
Pfizer Inc.

Pfizer  Global  Medical  Grants  (GMG)  supports  the  global  healthcare  community’s  independent  initiatives (e.g.,  research,  quality  improvement, or  education)  to improve  patient  outcomes  in  areas  of  unmet medical  need  that  are  aligned  with Pfizer’s  medical  and/or  scientific  strategies. Pfizer’s  GMG  competitive grant  program  involves  a  publicly  posted  general  Request  for  Proposal  (RFP) that  provides  detail  regarding a  general  area  of  interest,  sets  timelines  for  review  and  approval,  and  uses an internal  Pfizer  review  process to  make final  grant  decisions.  Organizations  are invited to submit  an application  addressing the  knowledge  gaps  as  outlined in  the  specific  RFP. 

The current standard of care in the treatment of first-line mRCC is combination immunotherapy with or without tyrosine kinase inhibitors.  In this setting, therapy management and/or adverse-event management are important components of care that may improve outcomes for patients with RCC.   Understanding adverse event etiology especially when overlapping toxicities are a concern may be an important consideration when treating first-line mRCC. 

Projects that will be considered for Pfizer support will focus only on two areas:

1. Nursing or pharmacist education programs or resources that nurses or pharmacists can use as they care for patients with RCC

2. Patient education programs or resources that patients can use as they make decisions about their own care and treatment 

Grant Application due date: March 22, 2022 

Agency Website

Eligibility Requirements

Geographic Scope:

Primary geography of interest:  United States

Secondary geography of interest:  The five European countries of France, Germany, Italy, Spain and United Kingdom

Projects may take place in or focus on learners in just one country or can have multi-country or cross-region reach.  Applicants are encouraged to apply for support for programs within their primary area of geographic strength or expertise. 

• The following types of organizations may apply: patient advocacy groups, nursing or pharmacy schools; healthcare institutions (both large and small); professional associations and societies; medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement.   • If the project involves multiple departments within an institution and/or between different institutions / organizations / associations. all institutions must have a relevant role and the requesting organization must have a key role in the project. • For projects offering continuing education credit, the requesting organization must be accredited. 

Amount Description

• Individual projects requesting up to $200,000 will be considered. The estimated total available budget related to this RFP is $500,000.

• Expected typical grant range:  $20,000 to $200,000.  For example, smaller, local, or single healthcare institution projects should be at the lower end of this range. 

Funding Type





Curriculum Development
Medical - Clinical Science

External Deadline

March 22, 2022